U
Morphic Medical, Inc. GIDYL
OTC PK
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 6/15/2022Downgrade
GI Dynamics, Inc. (GIDYL) was downgraded to E- from E on 6/15/2022 due to a decline in the volatility index.
E
Sell 5/31/2022Upgraded
GI Dynamics, Inc. (GIDYL) was upgraded to E from E- on 5/31/2022 due to an increase in the volatility index.
E
Sell 12/20/2021Downgrade
GI Dynamics, Inc. (GIDYL) was downgraded to E- from E on 12/20/2021 due to a noticeable decline in the volatility index and total return index.
E
Sell 11/11/2021Upgraded
GI Dynamics, Inc. (GIDYL) was upgraded to E from E- on 11/11/2021 due to a noticeable increase in the total return index and volatility index.
E
Sell 9/1/2021Downgrade
GI Dynamics, Inc. (GIDYL) was downgraded to E- from D- on 9/1/2021 due to a decline in the valuation index.
D
Sell 9/15/2020Downgrade
GI Dynamics, Inc. (GIDYL) was downgraded to D- from D on 9/15/2020 due to a noticeable decline in the total return index and volatility index.
D
Sell 8/31/2020Upgraded
GI Dynamics, Inc. (GIDYL) was upgraded to D from D- on 8/31/2020 due to a substantial increase in the valuation index and volatility index.
D
Sell 8/7/2020Upgraded
GI Dynamics, Inc. (GIDYL) was upgraded to D- from E+ on 8/7/2020 due to a noticeable increase in the total return index, valuation index and volatility index.
E
Sell 8/6/2020Downgrade
GI Dynamics, Inc. (GIDYL) was downgraded to E+ from D- on 8/6/2020 due to a decline in the volatility index.
D
Sell 7/31/2020None
Morphic Medical, Inc. (GIDYL) was downgraded to D- from U on 07/31/2020.
Weiss Ratings